Literature DB >> 17212729

Osteoporosis in haemophilia - an underestimated comorbidity?

T A Wallny1, D T Scholz, J Oldenburg, C Nicolay, S Ezziddin, P H Pennekamp, B Stoffel-Wagner, C N Kraft.   

Abstract

A relationship between haemophilia and osteoporosis has been suggested, leading to the initiative for a larger study assessing this issue. Bone mineral density (BMD) was measured by osteodensitometry using dual energy X-ray absorptiometry (DEXA) in 62 male patients with severe haemophilia A; mean age 41 +/- 13.1 years, mean body mass index (BMI) 23.5 +/- 3.6 kg m(-2). Using the clinical score suggested by the World Federation of Hemophilia, all patients were assessed to determine the severity of their arthropathy. A reduced BMD defined as osteopenia and osteoporosis by World Health Organization criteria was detected in 27/62 (43.5%) and 16/62 (25.8%) patients, respectively. Fifty-five of sixty-two (88.7%) patients suffered from haemophilic arthropathy. An increased number of affected joints and/or an increased severity were associated with lower BMD in the neck of femur. Pronounced muscle atrophy and loss of joint movement were also associated with low BMD. Furthermore, hepatitis C, low BMI and age were found to be additional risk factors for reduced BMD in the haemophiliac. Our data shows that in haemophilic patients osteoporosis represents a frequent concomitant observation. The main cause for reduced bone mass in the haemophiliac is most probably the haemophilic arthropathy being typically associated with chronic pain and loss of joint function subsequently leading to inactivity. Further studies including control groups are necessary to elucidate the impact of comorbidities such as hepatitis C or HIV on the development of osteoporosis in the haemophiliac.

Entities:  

Mesh:

Year:  2007        PMID: 17212729     DOI: 10.1111/j.1365-2516.2006.01405.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  20 in total

Review 1.  Bleeding disorders and reduced bone density.

Authors:  Hassan Mansouritorghabeh; Zahra Rezaieyazdi
Journal:  Rheumatol Int       Date:  2010-05-27       Impact factor: 2.631

2.  Evaluation of bone mineral density and related parameters in patients with haemophilia: a single center cross-sectional study.

Authors:  Hatice Demet Kiper Unal; Melda Comert Ozkan; Fatos Dilan Atilla; Zuhal Demirci; Nur Soyer; Ilgin Yildirim Simsir; Ozgur Omur; Kazim Capaci; Guray Saydam; Fahri Sahin
Journal:  Am J Blood Res       Date:  2017-11-01

3.  Serum Sclerostin Level and Bone Mineral Density in Pediatric Hemophilic Arthropathy.

Authors:  Dalia M E El-Mikkawy; Mohja A Elbadawy; Shereen M Abd El-Ghany; Dalia Samaha
Journal:  Indian J Pediatr       Date:  2019-01-22       Impact factor: 1.967

4.  Evaluation of bone mineral density (BMD) and indicators of bone turnover in patients with hemophilia.

Authors:  Mehmet Dagli; Ali Kutlucan; Sedat Abusoglu; Abdulkadir Basturk; Mehmet Sozen; Leyla Kutlucan; Ali Unlu; Farise Yilmaz
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

5.  Bone density in haemophilia: a single institutional cross-sectional study.

Authors:  C L Kempton; A Antun; D M Antoniucci; W Carpenter; M Ribeiro; S Stein; L Slovensky; L Elon
Journal:  Haemophilia       Date:  2013-08-01       Impact factor: 4.287

6.  Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement.

Authors:  A G Lau; J Sun; W B Hannah; E W Livingston; D Heymann; T A Bateman; P E Monahan
Journal:  Haemophilia       Date:  2014-04-08       Impact factor: 4.287

7.  Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Authors:  Marc Baud'huin; Laurence Duplomb; Stéphane Téletchéa; Céline Charrier; Mike Maillasson; Marc Fouassier; Dominique Heymann
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

8.  Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.

Authors:  Coline Haxaire; Narine Hakobyan; Tania Pannellini; Camila Carballo; David McIlwain; Tak W Mak; Scott Rodeo; Suchitra Acharya; Daniel Li; Jackie Szymonifka; Xiangqian Song; Sébastien Monette; Alok Srivastava; Jane E Salmon; Carl P Blobel
Journal:  Blood       Date:  2018-05-18       Impact factor: 22.113

9.  Osteoporosis in haemophilic patient, rehabilitative aspects.

Authors:  Patrizia Franco
Journal:  Clin Cases Miner Bone Metab       Date:  2012-09-30

10.  Evaluation of osteoporosis in hemophilic arthropathy patients: correlation with disease severity and serum trace minerals.

Authors:  Eiman Mahmoud Ghaniema; Sahar Fathi Ahmed; Irene Raouf Amin; Maryse Soliman Ayoub
Journal:  J Osteoporos       Date:  2011-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.